Skip to main content
. 2023 Dec 3;11(5):2305063. doi: 10.1002/advs.202305063

Figure 6.

Figure 6

The osteogenic differentiation potential of DPSCs. A) Expression levels of BSP II in different groups by western blot. B) The quantization of BSP II expression by ImageJ software (n = 3). C) Immunofluorescence co‐staining of BSP II (red) and DMP1 (green) by CLSM in different groups. Scale bar = 100 µm. D, E) Quantitative analysis of the MFI of BSP II (D) and DMP1 (E) in immunofluorescence co‐staining results (n = 3). F) Representative images of H&E staining in the brain, heart, liver, spleen, lung, and kidney from WT mice with different treatments. Scale bar = 100 µm. (B, C, D) Data are presented as mean ± SD (one‐way ANOVA and Sidak's multiple comparison tests, ## p < 0.01 versus sham group, and * p < 0.05, ** p < 0.01 versus pulpitis group or DPNMs group, ns means no significance).